| Logo | Name | Σ | ||
|---|---|---|---|---|
 | Sanofi We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare Tags: CAC40 Sectors: | 3559 | 2655 | 836 |
 | Capgemini Get the future you want Capgemini is a global business and technology transformation partner, helping organizations to accelerate their dual transition to a digital and sustainable world, while creating tangible impact for enterprises and society. It is a responsible and diverse group of 340,000 team members in more than 50 countries. With its strong over 55-year heritage, Capgemini is trusted by its clients to unlock the value of technology to address the entire breadth of their business needs. It delivers end-to-end services and solutions leveraging strengths from strategy and design to engineering, all fueled by its market leading capabilities in … Tags: CAC40 Sectors: | 4013 | 3134 | 586 |
 | Dia & Co The Challenge: 67% of American women wear sizes 14+—that’s 100 million women. Yet this majority is systematically underserved by the retail industry. The plus size community faces paltry options, unwelcoming environments, and a lack of representation—all adding up to a disappointing experience with style. Our Vision: Style freedom through a life well-lived The Dia & Co Solution: Dia & Co is the only retail service dedicated to meeting the plus size community’s full range of style needs. We’re applying the best of data and technology to serve women who have been ignored for far too long—from developing the shopping experiences … Sectors: | 2360 | 1871 | 335 |
 | imec Imec is a world-leading R&D and innovation hub in nanoelectronics and digital technologies. At imec, we shape the future by enabling nano- and digital technology innovation that enhances quality of life—together with partners from the industry, government, and academia. Our R&D is built on three core pillars: - a unique 2.5-billion-euro 300mm semiconductor pilot line - over 5,500 colleagues from over 96 countries - an ecosystem of 600+ world-leading industry partners and a global academic network Since 1984, imec quickly made its name as the leading research hub for advanced CMOS scaling and continues to set the course for the … | 976 | 528 | 511 |
 | Avolta Leading Tech M&A Advisor in Europe With more than 100 deals closed in 8 years, Avolta Partners has proven to be one of the most active M&A advisors in Europe in the Tech Industry. For more information, visit www.avoltapartners.com Venture Capital, Fundraising, M&A, Corporate Finance, and Tech Sectors: | 1105 | 111 | 987 |
 | Regeneron At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in. Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media. An … Sectors: | 364 | 278 | 23 |
 | Moderna Our mission is to deliver the greatest possible impact to people through mRNA medicines. At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using … Sectors: | 713 | 558 | 84 |
 | Deloitte Deloitte drives progress. Our firms around the world help clients become leaders wherever they choose to compete. Deloitte invests in outstanding people of diverse talents and backgrounds and empowers them to achieve more than they could elsewhere. Our work combines advice with action and integrity. We believe that when our clients and society are stronger, so are we. Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited (“DTTL”), its global network of member firms, and their related entities. DTTL (also referred to as “Deloitte Global”) and each of its member firms are legally separate and independent entities. DTTL … Sectors: | 6152 | 5122 | 238 |
Pharmaceutical